These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 36938123)
1. The role of community pharmacies in the HIV and HCV care continuum. Kherghehpoush S; McKeirnan KC Explor Res Clin Soc Pharm; 2023 Mar; 9():100215. PubMed ID: 36938123 [TBL] [Abstract][Full Text] [Related]
2. Pharmacist-led HIV and hepatitis C point-of-care testing and risk mitigation counseling in individuals experiencing homelessness. Kherghehpoush S; McKeirnan KC Explor Res Clin Soc Pharm; 2021 Mar; 1():100007. PubMed ID: 35479505 [TBL] [Abstract][Full Text] [Related]
3. Pharmacists' Opinions on the Implementation of HIV and HepC Point-of-Care-Testing in a U.S. Pharmacy Chain. So E; Brands M; Suomala E; Ogden B; Riss J; Cernasev A; Schommer J Innov Pharm; 2019; 10(1):. PubMed ID: 34007531 [TBL] [Abstract][Full Text] [Related]
4. Innovating the Model for Student Pharmacists to Increase Access to Hepatitis C Testing (Project IMPACT). Januszka J; Notarianni V; Devenny E; Harris E J Am Pharm Assoc (2003); 2023; 63(4):1217-1221. PubMed ID: 37037394 [TBL] [Abstract][Full Text] [Related]
5. Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study. Kelly DV; Kielly J; Hughes C; Gahagan J; Asghari S; Hancock S; Burt K; Smyczek P; Charlton C; Nguyen H BMC Public Health; 2020 May; 20(1):639. PubMed ID: 32380978 [TBL] [Abstract][Full Text] [Related]
7. Implementation and Evaluation of a Collaborative, Pharmacy-Based Hepatitis C and HIV Screening Program. Klepser DG; Klepser ME; Peters PJ; Hoover KW; Weidle PJ Prev Chronic Dis; 2022 Dec; 19():E83. PubMed ID: 36480802 [TBL] [Abstract][Full Text] [Related]
8. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009. Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G; MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587 [TBL] [Abstract][Full Text] [Related]
9. Community pharmacy delivered PrEP to STOP HIV transmission: An opportunity NOT to miss! Lopez MI; Grant RM; Dong BJ J Am Pharm Assoc (2003); 2020; 60(4):e18-e24. PubMed ID: 32165026 [TBL] [Abstract][Full Text] [Related]
11. Attitudes toward pharmacy-based HCV/HIV testing among people who use drugs in rural Kentucky. Duong M; Delcher C; Freeman PR; Young AM; Cooper HLF J Rural Health; 2022 Jan; 38(1):93-99. PubMed ID: 33666274 [TBL] [Abstract][Full Text] [Related]
12. Impact of a clinical pharmacist within an HIV PrEP program for patients experiencing homelessness. McElyea J; Bistransin K; Bana S; Alvarez KS; Brown LS; Persaud D; King H J Am Pharm Assoc (2003); 2023; 63(1):324-329. PubMed ID: 36184385 [TBL] [Abstract][Full Text] [Related]
13. Adaptation of POCT for pharmacies to reduce risk and optimize access to care in HIV, the APPROACH study protocol: examining acceptability and feasibility. Kielly J; Kelly DV; Hughes C; Day K; Hancock S; Asghari S; Gahagan J; Marra C; Nguyen H Pilot Feasibility Stud; 2018; 4():59. PubMed ID: 30788134 [TBL] [Abstract][Full Text] [Related]
15. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial. Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210 [TBL] [Abstract][Full Text] [Related]
16. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center. Isho NY; Kachlic MD; Marcelo JC; Martin MT J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379 [TBL] [Abstract][Full Text] [Related]
17. Community pharmacist engagement in HIV and HCV prevention: Current practices and potential for service uptake. Dowling-McClay K; Mathis SM; Hagemeier N Explor Res Clin Soc Pharm; 2021 Dec; 4():100088. PubMed ID: 35479840 [TBL] [Abstract][Full Text] [Related]
18. Addressing Barriers to HIV Point-of-Care Testing in Community Pharmacies. McKeirnan K; Kherghehpoush S; Gladchuk A; Patterson S Pharmacy (Basel); 2021 Apr; 9(2):. PubMed ID: 33923668 [TBL] [Abstract][Full Text] [Related]
19. Pharmacist Comfort and Awareness of HIV and HCV Point-of-Care Testing in Community Settings. Min AC; Andres JL; Grover AB; Megherea O Health Promot Pract; 2020 Sep; 21(5):831-837. PubMed ID: 31257939 [TBL] [Abstract][Full Text] [Related]